Tag: research

Following successful SCC audit, CNL is ready to perform pre-clinical studies for growing radiopharmaceutical industry as GLP-compliant laboratory

Burlingame, CA, July 15, 2025 (GLOBE NEWSWIRE) -- The global Vitrification Market is estimated to be valued at USD 10.82 Bn in 2025 and is expected to reach USD 31.15 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.3% from 2025 to 2032. The vitrification market is witnessing growing demand due to its expanding applications in biobanking, assisted reproductive technologies, and cryopreservation of oocytes, embryos, and stem cells. This technique offers faster cooling rates and higher cell survival compared to conventional freezing, making it increasingly preferred in fertility clinics and research institutions. Market growth is also driven by advancements in cryoprotectant solutions and rising awareness of fertility preservation. Opportunities lie in emerging markets, technological innovations, and collaborations between biotech firms and healthcare providers to improve storage protocols and expand access to vitrification services.

Brewster, NY, July 15, 2025 (GLOBE NEWSWIRE) --  The Little John Foundation is proud to announce the opening of the Victoria Lowry Dream Big Center at Brewster High School, a new educational initiative designed to provide students with tools and experiences to help them explore their full potential. The center honors the legacy of Victoria Lowry, a beloved former staff member of Brewster’s College and Career Room in the 1990s, who was known for her compassionate guidance and deep belief in every student's future.

CHICAGO, July 15, 2025 (GLOBE NEWSWIRE) -- Chicago Children’s Museum collaborated in a volunteer initiative alongside the SBB Research Group Foundation, which partners with local nonprofits through its Champion A Charity Program.   

MORRISTOWN, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- Piston Bio LLC, a biotechnology company developing both small molecules and biologics for the treatment of cancer, today announced that its scientific advisors have endorsed the potential of its next-generation therapeutic designed to induce tumor surface antigens and prevent immune escape. The endorsement follows a scientific advisory board meeting convened last month to review nonclinical data.